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PENETRATING KERATOPLASTY: THE SEARCH FOR A SUTURELESS 
SOLUTION 
FAISAL AL BAHRANI 
ABSTRACT 
 Specific Aim: Worldwide, there is a deficiency in the availability and the 
outcomes of corneal transplants procedures. The use of sutures in the various 
types of corneal transplant procedures increases the skill requirements for 
performing the procedure in addition to bringing about various suture-related 
complications. In order to avoid these complications and to make the procedure 
easier to perform, it is vital to review the properties and availability of various 
surgical adhesives in order to assess their potential as candidates for replacing 
suture use in corneal transplant procedures. The focus in this paper will be on 
the most prominent of these procedures: the penetrating keratoplasty procedure. 
 Recent Findings: Surgical adhesives that could potentially act as 
replacements or adjuncts to suture use in the penetrating keratoplasty procedure 
include homologous fibrin adhesives, polyethylene glycol sealants, cyanoacrylate 
glue, and poly [glycerol-sebacate-acrylate] (PGSA) glue. Polyethylene glycol 
sealants, when used as adjuncts to suture use in keratoplasty procedures lead to 
significant levels of wound dehiscence. Fibrin glues have been found to reduce 
the amount of sutures required in a “top hat” wound configuration penetrating 
keratoplasty when used as an adjunct to sutures in binding the donor button in 
place. Cyanoacrylate glues, although having higher levels of adhesive strength 
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than fibrin glue, lead to various unwanted side effects. Lastly, PGSA glue, given 
its recent development, remains an uncertainty due to the lack of research on it. 
 Summary: Overall, use of homologous fibrin glues is currently the most 
likely way to reduce the use of sutures in the penetrating keratoplasty procedure. 
Its use could lead to shorter operative times, fewer complications, reductions in 
cost, and higher availability for corneal transplant procedures. However, with 
further investigation, PGSA glue may prove to be a better candidate for the 
replacement of sutures than fibrin glues.  
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INTRODUCTION 
 
 Corneal transplantation is a well established form of treatment for various 
life-altering corneal pathologies including bullous keratopathy, dystrophies, 
keratoconus, trauma, and corneal scarring. To emphasize the impact of those 
pathologies, keratoconus, known to occur in up to 2.3% of the population in 
places such as India, is responsible for 5% of all cases of blindness (Arora et al., 
2015). Corneal transplantations are carried out through one of a handful of 
different procedures including penetrating keratoplasty, deep anterior lamella 
keratoplasty (DALK), Descemet stripping endothelial keratoplasty (DSEK), and 
Descemet membrane endothelial keratoplasty (DMEK). The Eye Bank 
Association of America recently revealed that they distributed 88,227 corneal 
tissues in 2012 that were used in corneal transplants worldwide (Ple-Plakon & 
Shtein, 2014). Of those tissues, 36,716 were used for penetrating keratoplasty 
and 24,227 were used for lamellar keratoplasty.  
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Figure 1. Diagram of the Eye. (Taken from “Fuchs Corneal Dystrophy,” n.d.) 
 
Although the amount of corneal transplants performed across the globe 
each year is in the order of about one hundred thousand procedures, it has been 
estimated that approximately 10 million people worldwide would benefit from the 
procedures (Price et al., 2010). In addition to the problem of supply, the quality of 
corneal transplants in terms of outcomes in developing countries is significantly 
worse than those in more developed countries, leading to a high proportion of 
repeated surgeries (Garg et al., 2005).  This lack in availability and quality can be 
attributed to a lack of skilled surgeons, less refined eye banking infrastructure, 
and less developed clinical facilities. To address these problems, changes can 
be made to the penetrating keratoplasty procedure to decrease the skill intensive 
nature of the procedure to allow more surgeons to perform the procedure. The 
problem can be alleviated by altering the painstaking and time consuming 
suturing step of the penetrating keratoplasty procedure to make it sutureless, 
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which would make the procedure quicker, easier to perform, and would 
potentially decrease the risk of certain complications. In this paper, the potential 
avenues for making the penetrating keratoplasty procedure sutureless will be 
noted and their respective advantages and drawbacks will be discussed with 
respect to penetrating keratoplasty performed with traditional 10-0 nylon sutures. 
Penetrating Keratoplasty 
Penetrating keratoplasty has been and has remained the most prominent 
form of corneal transplantation. Since its inception and after the first successful 
procedure in 1905, various advances to medicine have contributed to improved 
outcomes and surgical efficiency. The procedure itself is currently carried out 
through the use of a corneal trephine, a circular cutting device, or through a 
femtosecond laser, which make a deep, circular, cut in the cornea (Brightbill, 
2009). The patient’s diseased circular disc of cornea is then removed and 
replaced with a similarly shaped, healthy, donor cornea. A radial pattern of 
sutures (see Figure 2), usually nylon and of the 10-0 USP designation, is then 
used to bind the donor cornea in place and to promote healing of the epithelial 
tissue. The first suture is placed at the 12 o’clock position, passed through the 
donor and host tissues, and tied with a triple knot followed by two single loops 
(the 3-1-1 knot) or a slipknot. The second suture is placed on the opposite side of 
the circular ring of donor cornea and tied in a similar manner. This suturing 
occurs at various angles radially until about 16, equally spaced, sutures are 
placed.  
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Figure 2. Example of a Penetrating Keratoplasty Post-Operative Eye. In this 
particular example, the surgeon used both 10-0 and 11-0  USP designation 
sutures (Taken from McGhee et al., 2013).  
 
General indications for the surgery are various and include corneal 
pathologies such as trauma, keratoconus, repeat grafts from previous surgeries, 
infections, bullous keratopathies, and dystrophies (see Figure 3). Due to the 
immunological privilege of the eye, corneal transplant procedures are able to 
treat these pathologies at a success rate as high as 90% (Niederkorn, 2010). 
Despite the success rates, penetrating keratoplasty procedures require intensive 
follow up in order to address the various complications that occur. Known 
complications include induced astigmatism, graft rejections, wound leakage and 
dehiscence, secondary glaucoma, and ocular surface diseases (Ple-Plakon & 
Shtein, 2014). The induced astigmatism is due to the wound alignment of the 
donor cornea with the host in conjunction with the varying tightness of the 
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sutures that form a ring around the cornea and bind it in place. After the surgery, 
multiple follow-ups are required to manage the astigmatism through selective 
removal of tight sutures and through refractive lenses (Fares et al., 2012). 
 
 
Figure 3. Eye with Granular Dystrophy (Groenouw Type I). Severe cases of 
granular dystrophy can be treated by corneal transplants (Taken from 
Ophthalmology, 2011). 
 
Deep Anterior Lamellar Keratoplasty 
 Deep Anterior Lamellar Keratoplasty, or DALK, is a form of corneal 
transplantation which involves the selective removal of a partial, anterior, 
segment of the cornea (See Figure 4). Unlike penetrating keratoplasty, the partial 
segment that is removed does not include the underlying endothelium and 
Descemets membrane. The removal occurs in a similar fashion to the 
penetrating keratoplasty but also requires the injection of an air bubble to 
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separate the anterior cornea from the rest of the cornea (Anwar & Teichmann, 
2002). Once the segment is cut out, it is replaced with a healthy donor’s anterior 
cornea and sown in place. Since DALK does not replace the endothelium, the 
primary indications are limited to those that only affect the anterior segment and 
include keratoconus and corneal scarring. Due to its less invasive nature and 
decreased graft rejection risk, DALK is generally preferred over penetrating 
keratoplasty in cases where the host has a healthy endothelium (Rajan, 2014). 
 
 
Figure 4. Diagram of a Post DALK Cornea. The diagram portrays the partial 
segment of the anterior cornea that is replaced. The host retains their 
endothelium (Taken from “Kornea Nakli - DALK yöntemi,” n.d.). 
 
The complications for DALK are less severe than those of penetrating 
keratoplasty. Since the host endothelium remains intact, there is minimal risk of 
endothelial graft rejection (Cassidy et al., 2013). However, DALK patients 
experience similar astigmatism rates from suture tightness and wound alignment, 
as well as also experience the risk of having their DALK procedures cause 
perforation of the Descemets membrane, which requires the DALK procedure to 
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be converted to a penetrating keratoplasty (Cassidy et al., 2013). The conversion 
rate has been observed to vary from 2.5% to 9.6% of the procedures (Ple-Plakon 
& Shtein, 2014). In addition to the conversion risk, DALK is generally considered 
to be more technically demanding than penetrating keratoplasty (See Table 1). 
Due to these limitations in both indications and technical requirements, the 
remainder of the paper will focus on the penetrating keratoplasty procedure as a 
means of increasing the availability of corneal transplants. 
  
Table 1. Advantages and Disadvantages of DALK Compared to Penetrating 
Keratoplasty. (Taken from Cassidy et al., 2013). 
 
 
The Cons of Suture Use in Penetrating Keratoplasty 
 The use of sutures in penetrating keratoplasty procedures is associated 
with a variety of disadvantages.  The first of which is the skill intensive and time 
consuming nature of corneal suturing. As stated above, those properties add to 
the overall lack of availability of corneal transplants in the developing world since 
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it increases both the need for skilled surgeons to perform the surgery and could 
add to the poorer outcomes in those countries if the surgery is not performed 
adequately.  
In the realm of corneal suturing, it has been shown that an experienced 
surgeon, when compared to novices or trainees, takes far less time performing a 
3-1-1 knot with a 10-0 nylon suture through the cornea and with fewer, and 
shorter, movements (Saleh et al., 2006; See Table 2). As indicated in 2012 by a 
questionnaire sent to ophthalmic consultants identified by the Royal College of 
Ophthalmology, 10-0 nylon sutures used in a 3-1-1 knot is generally preferred for 
high risk penetrating keratoplasty cases (Lee et al., 2012). This fact, in addition to 
the fact that the 3-1-1 knot can withstand more force before failure than slipknots, 
makes the capacity to perform the 3-1-1 knot with ease more of a requirement for 
corneal transplant surgeons (Lutchman et al., 2014). Since the 3-1-1 knot has to 
be performed approximately sixteen times in a standard penetrating keratoplasty, 
the difference in time an expert surgeon would require compared to a novice or a 
trainee to perform a 3-1-1 knot would effectively be multiplied by sixteen for the 
total procedure, leading to a 40 minute mean difference between a novice and an 
expert surgeon and a 10 minute mean difference between a trainee and an 
expert to perform a penetrating keratoplasty based on the suturing step 
alone(Saleh et al., 2006). An example of how alternatives to suture use in 
ophthalmology can decrease operative time occurred in 2012, when a study was 
performed where pterygium excision procedures were performed with both 
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sutures and fibrin glues. The results indicated that glue use decreased the mean 
pterygium excision operative time by about 36% (Cha et al., 2012). In essence, 
surgical skill deficiency can manifest itself through the suturing step of the 
penetrating keratoplasty, which makes that step a viable target for reducing both 
the operative time and the skill requirement. 
 
Table 2. Summary of Results for Corneal Suture Insertion with Differing 
Grades of Surgeon Experience. (Taken from Saleh et al., 2006). 
 
  
The next issue that arises from suture use in penetrating keratoplasty is 
that of the induced astigmatism that arises via the varying tightness of the 
sutures binding the graft in place and the extensive post-operative suture 
removal. Suture tension and suture removal have been noted along with the 
instability of keratoplasty wounds as the predominant causes of keratoplasty 
induced astigmatism (Hoppenreijs et al., 1993). The suture tension tugs and 
alters the keratometry of the cornea, which can lead to the development of a 
significant astigmatism. This astigmatism causes post-operative patients to 
experience poor uncorrected vision and require prescription lenses to correct for 
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the astigmatism. Since the follow-up visits for the keratoplasty procedure require 
gradual removal of the stitches, the astigmatism will begin to change for every 
suture removed. This adds further complications to the correction of the patients’ 
vision and makes maintenance of properly corrected vision via lenses less 
practical and costly. The high astigmatism can lead to other problems as well. 
Premature suture removal performed with the intent of decreasing astigmatism 
has been shown to be a lead cause in post-operative wound gaps and 
dehiscence (Fujii et al., 2014).  
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Figure 5. Suture Removal Effect on Post Keratoplasty Astigmatism. 
A,C, and E are progressive corneal topographies. B,D, and E are eye images 
that correspond, respectively, to the A, C, and E topographies. The arrows 
indicate where sutures were removed. Changes in the magnitude and axis of 
astigmatism can be noted. (Taken from Sarhan et al., 2010) 
 
Preliminary studies have indicated that alteration of the suturing step of 
the penetrating keratoplasty procedure may solve the astigmatism-based 
complications. In 2013, a study was performed in which lamellar keratoplasty 
procedures were performed on multiple groups of rabbits, of which some had the 
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donor corneas attached with 8 bite sutures and others through synthetic glues 
(Cho et al., 2013). The group that had their grafts sutured with 8 bite sutures 
experienced significant differences in keratometry while the synthetic glue group 
experienced no significant changes in keratometry. This indicates the possibility 
that replacing the use of sutures with glues or other alternatives could be an 
efficient way to reduce penetrating keratoplasty induced astigmatism in addition 
to decreasing the required suture removal follow-up visits and astigmatism 
related complications. Synthetic glues as alternatives to sutures in penetrating 
keratoplasty procedures will be discussed in further detail later.   
 Lastly, suture use can lead to a variety of additional physical complications 
in keratoplasty procedures such as loose sutures, wound leakage, infection, 
wound dehiscence, ulcerations, and even graft rejection. It has been shown that 
up to 34% of keratoplasty cases can show these complications (Christo et al., 
2001). The most common symptom is that of epithelial erosion, causing 
discomfort, mild pain, and the foreign body sensation for the patients. The most 
severe series of complications, however, results from spontaneous loose 
sutures. These sutures require removal followed by repair of the graft by means 
of resuturing. Approximately 13% of those loose suture scenarios resulted in a 
graft reaction, followed by complete graft failure. The data approximating the 
incidence of these complications as well as their timing can be found below. 
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Table 3. Incidence and Timing of Suture Related Complications Following 
Penetrating Keratoplasty. Taken from (Christo et al., 2001) 
 
 
Ideal Characteristics of a Sutureless Alternative 
 In order to assess the potential of a sutureless alternative, the qualities of 
interest must be defined. First and foremost, an alternative to sutures in 
penetrating keratoplasty procedures must be able to generate the required 
amount of tensile strength to hold the donor cornea in place. This tensile strength 
must be maintained for a long enough duration that so that healing is promoted.  
Additionally, adequate tensile strength would prevent wound dehiscence, wound 
leakage, and other similar complications that are known to occur with suture use. 
The required forces needed to break and unravel a 10-0 nylon suture 3-1-1 knot 
are .71 N  and .48 N respectively (Lutchman et al., 2014). If an alternative is able 
to withstand similar forces without breaking, then it can act as a full replacement 
when it comes to this criterion.  
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 Second, the ideal alternative should not obstruct or alter vision in any way. 
This includes significant alterations to keratometry and astigmatism.  Additionally, 
the alternative should not cause opacification of the cornea or lead to any 
opaque materials existing within the humour.  
Inflammation, irritation, and pain should be kept to a minimum. In order to 
minimize the level of irritation and inflammation a patient experiences, the 
alternatives should have a high degree of biocompatibility with human corneal 
tissue. High levels of biocompatibility would also minimize discomfort and foreign 
body sensation.  
 The ideal alternative should also be safe and easy to use as compared to 
10-0 nylon sutures. This would improve the operative time and reduce the need 
for highly skilled surgeons and increase overall availability of corneal transplants. 
Additionally, the alternative should be biodegradable or easily removable within 
the six to nine month post-operative period. This characteristic would minimize 
the required follow-up visits when compared to the extended amount of follow-
ups required for suture removal. 
 Lastly, the ideal alternative would be cost effective, transportable, and 
widely producible. This characteristic would enable effective globalization of the 
technique for improved overall global availability. In the next section, the potential 
alternatives to sutures for the penetrating keratoplasty procedure will be 
highlighted and later compared to 10-0 nylon sutures with respect to these 
criteria. 
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SPECIFIC AIMS 
 The specific aim of this paper is to assess the properties, availability, cost, 
and current research on various potential alternatives to suture use for the 
penetrating keratoplasty procedure.  The alternatives will be assessed based 
upon the ideal characteristics of a suture replacement above. It is the author’s 
intent to find a replacement for sutures that will maximize the global availability, 
the ease, and the efficacy of the penetrating keratoplasty procedure while 
minimizing surgical and post-operative complications, operative time, and patient 
discomfort. Given the unique physiology of the eyes and the cornea, only 
experimental papers involving use of those alternatives on the eye and cornea 
will be considered. 
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PUBLISHED STUDIES 
 
 Sutures have been a cornerstone in surgery as a means of binding tissue 
and as promoters of healing. Over time, other mechanisms been developed and 
refined to accomplish similar goes. Examples include surgical staplers, 
adhesives, patches, and welding lasers. Tissue adhesives, especially, have seen 
wide use due to the ease of their application. Tissue adhesives have been 
localized to two primary categories: synthetic glues and biological glues. For the 
cornea, the main synthetic and biological glues that have seen extensive use are 
cyanoacrylate derivatives and fibrin based adhesives, respectively (Sinha et al., 
2009). New adhesives available for potential ophthalmic surgical use include 
polyethylene glycol adhesives and poly (glycerol-sebacate-acrylate) glue (Panda 
et al., 2009; Lang et al., 2014). Below, each of these suture alternatives will be 
highlighted with regard to relevant publications that reveal their potential worth as 
replacements and adjuncts to suture use in penetrating keratoplasty procedures. 
Afterwards, these alternatives will be discussed with respect to the criteria of an 
ideal replacement in order to identify the best possible alternatives. 
Fibrin Glues 
Properties 
Fibrin sealants act in a way that mimics the later parts of the natural 
coagulation pathway. The sealants are derived from plasma coagulation proteins, 
fibrinogens and thrombin. These two components are loaded into two syringes 
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that have a common port. Upon injection, the enzyme, thrombin, reacts with the 
fibrinogens to form fibrin monomers that create a gel matrix (See Figure 6). 
Factor XIII, which is present in the fibrinogen, acts to cross-link and stabilize the 
monomers. The concentration of thrombin determines the reaction rate and, thus, 
can be altered so that the rate of formation of the fibrin matrix can be tailored to 
specific uses (Atrah, 1994). For example, use of thrombin 500, a highly 
concentrated thrombin, would lead to a 10 second clot formation, whereas use of 
thrombin 4, a dilute thrombin, would require 60 seconds for clot formation. This 
variability in clot formation can be beneficial in keratoplasty procedures since 
time is required to properly align the donor tissue with the host’s tissue and clean 
excess glue. Although a delayed setting time is likely to be preferred, a surgeon’s 
particular preference and skill level can also play a role in which thrombin 
concentration is ideal. 
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Figure 6. Diagram of Fibrin Matrix Formation. Taken from (Chernysh et 
al., 2012). 
 
 An additional advantage to the use of fibrin glues with respect to sutures is 
the inherent biocompatibility and biodegradability of the mixture. They do not 
produce inflammation, necrosis, fibrosis, or foreign body reactions (Radosevich 
et al., 1997). The fibrin clot, itself, is broken down during the natural healing 
process. The process can take time ranging from days to weeks to completely 
break down, a variable based upon the concentration of the sealant and the 
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proteolytic activity of the treated area. During this time period, the fibrin sealant 
promotes tissue growth, healing, and angiogenesis (Matras, 1985).  
 The first drawback to the use of fibrin based adhesives is that the effective 
tensile strength of fibrin glues has not been adequately quantified. This is due to 
the variable nature of the glue composition and the tensile strength’s inherent 
dependence on external factors such as the tissue composition and the surface 
area of the target of adhesive application. Another example of tissue based 
limitations of fibrin sealant use, fibrin glues have been shown to work at peak 
effectiveness in primarily dry settings (Spotnitz, 2014). Since the penetrating 
keratoplasty procedure involves fluid exposure from both the humour of the eye 
and from topical anesthetics, fibrin glues are likely to be more viable for use in 
lamellar procedures since the endothelium prevents humour exposure. In 
addition, since the host maintains their endothelium, the graft-host interface has 
more surface area for glue adhesion in lamellar procedures than penetrating 
keratoplasty procedures, further increasing the viability disparity between the two 
types of corneal transplantation.  
In order for fibrin glues to adequately replace sutures in penetrating 
keratoplasty procedure, it is preferable that they reduce the operative times and 
the inherent skill requirement of the procedure. Studies have also shown that the 
effectiveness of fibrin glues in surgical procedures is in part determined by the 
surgeons previous experience with fibrin sealants (Wang et al., 2003). This 
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indicates that fibrin glue use does have a learning curve and may require 
significant practice for maximum efficacy.  
Additional drawbacks to fibrin glue use have been due to the method of 
fibrin adhesive preparation methods. Since the adhesive is derived from 
coagulation proteins, there exists a risk of transmitting diseases from the blood 
donors to the fibrin adhesive recipients (P A Everts, 2006). Additionally, the 
capacity to produce mass quantities of fibrin glue has been limited by its cost 
ineffective nature as a plasma based product. However, in 2008, Aizawa et al. 
presented a method of preparing large batches of thrombin, in the order of 
thousands of liters, from blood plasma through a series of separation techniques 
(Aizawa et al., 2008). They achieved a thrombin purity of 75%, sufficient for the 
production of fibrin adhesives. Additionally, the processed batches were run 
through various viral activity reduction techniques. The overall product was found 
to have a high degree of virus safety due to these steps. Lastly, the process was 
highly cost effective since it was produced from the waste fraction of the 
commercial production of Factor IX, a protease required in the treatment of 
Christmas disease. Through the technique presented by Aizawa et al., mass 
production of thrombin can increase the overall supply of fibrin glues and 
decrease their cost to make fibrin a more viable replacement to sutures.  
 In terms of efficacy, fibrin glues have been found to have a wide range of 
effective bond strengths, preparation times, cost effectiveness, and safety levels. 
As it stands, the safest fibrin glues are autologous fibrin adhesives, those derived 
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from a patient’s own blood, since the patient is not at risk of any foreign infectious 
contaminants (Siedentop et al., 2001). The primary drawbacks for those 
autologous fibrin adhesives are that they require time for preparation, facilities 
capable of producing the sealant, and also have significantly lower bonding 
power than homologous fibrin adhesives (See Figure 7). The preparation time 
required for the production of autologous fibrin adhesives is not necessarily a 
detriment to penetrating keratoplasty procedures, since the procedure is not 
generally performed as an emergency. However, the decreased bonding strength 
could lead to wound dehiscence.  
 
 
Figure 7. Bonding Power of Fibrin Glues on Pig Skin. Autologous fibrin 
tissue adhesives (AFTA) A, C, and E display significantly lower bonding power, in 
grams, than ViGuard and Tisseel, homologous fibrin tissue adhesives. Taken 
from (Siedentop et al., 2001) 
 22 
Availability 
Currently, only three topical fibrin sealants are approved by the FDA 
(“Fractionated Plasma Products - Fibrin,” n.d.). Tisseel (Baxter Healthcare Corp) 
was the first fibrin glue approved by the FDA in 1998. It is now joined by ARTISS 
(Baxter Healthcare Corp) and Evicel (OMRIS Biopharmaceuticals Ltd). In terms 
of the indications of use, fibrin sealants are currently only approved for use on 
skin graft and facial flap attachment procedures. Tisseel, Evicel, and ARTISS 
were found to have the high bonding strengths required for surgical use and are 
generally considered to be safe for use in humans. Tisseel comes in a syringe 
fully mixed (fibrinogen and thrombin), needs to be frozen for storage, and 
requires only five minutes or so for thawing (Spotnitz, 2014). Evicel also comes 
mixed in a syringe, can be preemptively thawed, and stored by means of 
refrigeration for up to a month. Given that keratoplasty procedures are not 
performed in emergency settings, the thawing and frozen storage aspects should 
not act as detriments to its use. These sealants are available for purchase at a 
cost of about $50 per milliliter (Spotnitz, 2012). 
 Experimental Ophthalmic Surgeries Using Fibrin 
Although the true tensile strength of fibrin glues has been difficult to 
quantify, fibrin glues have seen use in experimental keratoplasty procedures that 
has allowed comparison of their effectiveness to 10-0 nylon sutures. The first 
attempted introduction of fibrin glue to corneal transplants was performed by 
Katzin et al. in 1946 when penetrating keratoplasty procedures were performed 
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on rabbits with the help of fibrin adhesives (Katzin, 1946). The penetrating 
keratoplasty procedures were performed without sutures and with fibrinogen and 
applied thrombin as acting sealants. The grafts were retained with an 86% 
success rate. However, Katzin reported that the risk of wound dehiscence was 
too great to attempt the procedure on humans. Following this study, a multitude 
of other studies arose to better approach fibrin as an alternative and potential 
replacement for sutures in keratoplasty procedures. In 1975, Rosenthal et al. 
used a fibrinogen and thrombin mixture as a corneal adhesive in a sutureless 
lamellar keratoplasty in rabbits. They demonstrated a 50% sutureless graft 
retention rate (Rosenthal, Harbury, Egbert, & Rubenstein, 1975).  In 1978, 
Rosenthal et al. repeated the experimental use of fibrinogen and thrombin as 
replacements for sutures but for penetrating keratoplasty instead of lamellar 
(Rosenthal et al., 1978). For this experiment, a 75% graft retention rate was 
achieved. The authors noted that the material was easy to apply and did not 
cause inflammation or lid irritation. 
Since then, both surgical technique and fibrin glue preparation methods 
have progressed in quality. In 2007, Narendran et al. performed a novel DALK 
procedure on a 21 year old patient with keratitis (Narendran et al., 2007). Rather 
than using the standard radial sutures, they used Tisseel fibrin glue and overlay 
sutures to secure the donor tissue onto the host bed (See Figure 8). The glue 
was applied at the base of the donor button as pressure was applied with forceps 
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until the glue set. They found that this technique was time efficient and reduced 
suture related complications since the sutures were removed early. 
 
 
Figure 8. Post-Operative DALK Eye Set with Overlay Sutures and 
Fibrin Glue. The top image is of the eye a week after surgery and the bottom 
image is an image from four months after surgery. Taken from Narendran et al., 
2007. 
Also in 2007, Bahar et al. performed a series of penetrating keratoplasty 
procedures on human rims containing both cornea and sclera placed upon an 
artificial anterior chamber (Bahar et al., 2007).  Of the twenty rims, 8 underwent 
 25 
traditional penetrating keratoplasty, 6 underwent a “Top hat” penetrating 
keratoplasty, and the remainder underwent a “top hat” penetrating keratoplasty 
with fibrin glue (Tisseel) used on opposing wound edges. The results indicated 
that a “top hat” keratoplasty performed with the fibrin glue withstood more 
intraocular pressure before wound leakage and wound bursting occurred, when 
compared to traditional penetrating keratoplasty and “top hat” keratoplasty with 
sutures only. The results also indicated that the induced astigmatism in the “top 
hat” keratoplasty with fibrin group was only 2.5 D when compared to the 
traditional keratoplasty and the “top hat” keratoplasty, which induced an 
astigmatism of 3.1D each.  
The “top hat”, mentioned in the study above, refers to an alternative 
wound cutting method that alters the shape of the donor-host interface (Bahar et 
al., 2008). The “top hat” wound cut is produced by a cylindrical cut followed by a 
wider, ring shaped cut, forming the shape of a top hat (See Figure 9). The “top 
hat” configuration has been found to be the most effective configuration, when 
compared to the traditional, “mushroom”, “Christmas tree”, and “zig-zag” 
configurations in terms of the intraocular pressure required to cause wound 
leakage and wound bursting in penetrating keratoplasty post-operative eyes. This 
wound configuration not only provides mechanical support for prevention of 
wound leakage, but also increases the surface area on the donor-host interface 
to maximize the total tensile strength of the glues applied on those surfaces. Use 
of this wound configuration could increase the efficacy of any potential adhesive 
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used as a suture replacement through mechanical stabilization and surface area 
enhancement.  
 
 
Figure 9. Diagram of Various Wound Configurations for Penetrating 
Keratoplasty Procedures. Each of the images represent different cuts through 
the host and donor corneas. A) Traditional penetrating keratoplasty. B) “Top Hat” 
configuration. C) “Mushroom” configuration. D) “Zig-zag configuration”. E) 
“Christmas Tree” configuration. Taken from Buzzonetti et al., 2012. 
 
Cyanoacrylate Glues 
Properties 
Cyanoacrylate glues are a group of industrial, synthetic, glues that are 
known for their quick exothermic polymerization. The cyanoacrylate glue group 
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includes ethyl-2-cyanoacrylate, know commonly as super glue, n-butyl 
cyanoacrylate, methyl 2-cyanoacrylate, and 2-octyl cyanoacrylate. The structure 
of cyanoacrylate glues contains an ethylene group, a cyano group, and a variable 
length alkyl group, which determines the name of the glues (see Figure 10). 
 
 
Figure 10. Model of Cyanoacrylate Molecule. For cyanoacrylate glues, 
the R2 group would be a hydrogen and the R1 group corresponds to the variable 
alkyl group. Potential R1 variable groups include: a methyl group, an ethyl group, 
and an octyl group. 
 
Their use has generally been limited to the skin and external wounds due 
to inflammation that they induce (Panda et al., 2009). The inflammatory nature of 
these glues is due to their alkyl chains which, when broken down, generate 
cyanoacetate and formaldehyde. These products are difficult to metabolize, build 
up, and cause the inflammatory effects (García Cerdá et al., 2014). The length of 
the alkyl chains also determines the rate at with the glue fixates. The short alkyl 
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chain glues react and fixate very quickly, and release heat upon reacting. This 
makes short-chain cyanoacrylate glues, such as methyl 2-cyanoacrylate glue, 
unsuitable for use on human tissue (Matsumoto et al., 1967). Additionally, short 
alkyl chain cyanoacrylate glues generate formaldehyde and cyanoacetate faster 
than longer alkyl chain cyanoacrylate glues. This leads to build up of the 
inflammatory materials. 
The cyanoacrylate glues, when coming into contact with basic fluids and 
substances, polymerize and form long chains (Hollander & Singer, 1998). In 
terms of adhesive strength, comparative studies in rat models have shown that 
N-butyl-2-cyanoacrylate use for wound closure produced similar results to nylon 
suture use in terms of the healing process of the abdominal walls, but the 
cyanoacrylate group showed a higher tensile strength in wound closure 14 days 
into the healing process (Batista et al., 2008). Most studies, however, have 
suggested that sutures and tacks provide more overall tensile strength than 
cyanoacrylate adhesives (Ladurner et al., 2011). 
Availability 
Histoacryl Blue (Braun), an N-butyl-2-cyanoacrylate adhesive was the first 
commercially available. Additional commercially produced medical cyanoacrylate 
glues include Dermabond (Closure Medical Corporation), an octyl-2-
cyanoacrylate, and Indermil (Vygon), an n-butyl-2-cyanoacrylate. If kept 
refrigerated, cyanoacrylate glues have a shelf life of about one year  (Burchardt & 
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Merz, 2006). The cost of cyanoacrylate glues is approximated to be about $5 per 
milliliter.  
Experimental Opthalmic Surgeries Using Cyanoacrylate Glues 
It has been indicated that, when used in situ, cyanoacrylate glues tend to 
form an impermeable mass. These masses can form crusting, and in the case of 
use on the cornea, has been shown to lead to giant papillary conjunctivitis 
(Carlson & Wilhelmus, 1987). This, in addition to the inflammatory nature of 
formaldehyde as breakdown product, can lead to significant discomfort if used on 
a patient’s eyes. 
Studies have enabled comparison of cyanoacrylate glues to fibrin glues in 
a corneal setting. In 2003, Sharma et al. treated 41 patients with 3 mm corneal 
perforations. One group was treated with fibrin glue and the other with N-butyl-2-
cyanoacrylate. The results indicated that both glues successfully sealed the 
corneal perforation. The results also  indicated that the fibrin adhesives provided 
quicker healing, but took longer to set, requiring a few minutes to set compared 
to the few seconds required for cyanoacrylate (Sharma et al., 2003).  
 Additionally, in 2013, another study was performed to evaluate the 
effectiveness of tissue adhesives on corneal trauma cases. Corneal incisions in 8 
rabbits were sealed with either cyanoacrylate or fibrin glues. The results 
indicated that the fibrin glue polymerized at a slower rate when compared to 
cyanoacrylate glues, which gave surgeons time to manipulate the wound. 
Additionally, due to the quick polymerization of the cyanoacrylate glue, surgeons 
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were limited in their ability to manipulate the wound. The excess glue from 
cyanoacrylate use was also shown to cause the rabbits irritation (Papadopoulou 
et al., 2013).  
Polyethylene Glycol Glues 
 Properties 
 Polyethylene glycol sealants are formed through a combination of two 
polyethylene glycol polyethers that are able to cross link with the proteins found 
in the target tissues (Cosgrove et al., 2007). The polymerization results in a clear 
hydrogel that breaks down within 8 weeks. The products of breakdown are 
generally filtered by the kidneys when applied in areas within that time period 
with sufficient vascular access. The glues are synthetically produced and thus do 
not have a risk of transferring infectious agents. Additionally, the glue 
polymerizes in 5 seconds and reaches its maximum mechanical strength in 
approximately 60 seconds (Garcia-Morales et al., 2014). 
 The most notable disadvantageous property of polyethylene glycol glues, 
with respect to the aim of this paper, is that the adhesive can swell up to 4 times 
the volume of application within 24 hours (Garcia-Morales et al., 2014). If placed 
on the rim of the donor-cornea interface in penetrating keratoplasty procedures, it 
is likely that this change in volume will have detrimental effects to the patient’s 
vision or the healing of the cornea.   
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Availability 
 Available FDA approved polyethylene glycol sealants include DuraSeal 
(Covidien), ProGEL (NeoMend, Inc), and CoSeal (Baxter Healthcare 
Corporation). Approved indications for use include dura matter surgery, sealing 
lung tissue to prevent air leaks, and sealing blood vessels and arteries (Health, 
n.d.-a; Health, n.d.-b; Health, n.d.-c). The sealants can be stored at room 
temperature, but require about 1 to 2 minutes to mix the preparation, after which 
it must be used within two hours (Cosgrove et al., 2007). The cost of 
polyethylene glycol glues is approximated to be $56 per milliliter (Pocius, 2002). 
Experimental Ophthalmic Surgeries Using Polyethylene Glycol Glues 
 In 2003, Kalayci et al. attempted to seal 1-5 mm incisions on the cornea of 
rabbit eyes through the use of polyethylene glycol sealants. The experimental 
group was compared to the use of 10-0 nylon sutures. For all incision sizes, the 
results indicated that the intraocular pressure required to cause wound leakage 
was significantly higher in the group sealed by the polyethylene glycol glue 
(Kalayci et al., 2003).  
 Comparison of polyethylene glue efficacy in comparison to fibrin glues and 
sutures was made possible in 2013. Cho et al. conducted a study comparing the 
changes caused by sutures, fibrin glues, and polyethylene glues to the 
keratometry of rabbit eyes after lamellar keratoplasty. The rabbit grafts were set 
with eight sutures alone in one group, fibrin glue and four sutures in another, and 
polyethylene glue and four sutures in the last. The fibrin glue group showed no 
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hint of histological toxicity or inflammation. Polyethylene glycol showed moderate 
inflammation in the groups and limited wound repair when compared to sutures 
and fibrin glue. The authors concluded, based upon the results, that fibrin was a 
sufficient replacement for sutures in lamellar keratoplasty grafts, and that 
polyethylene glycol glues were not sufficient (Cho et al., 2013). 
Poly [Glycerol-Sebacate-Acrylate] Glue 
 Properties 
 Poly [Glycerol-Sebacate-Acrylate] (PGSA) is composed of 2 naturally 
occurring monomers and one synthetic monomer. Glycerol exists in the body as 
a substrate in reactions leading to the synthesis of lipids. Sebacate exists in the 
body as an intermediate of fatty acid reactions. 
 The glue itself was developed in 2014 by Lang et al. for the purpose of 
repairing blood vessels and heart defects. The glue exists as a combination of a 
PGSA prepolymer and a light-reactive initiator. When exposed to ultra violet light, 
via a curing pen light, the adhesive forms cross-links and begins to set (Lang et 
al., 2014). The adhesive reaches its maximal tensile strength after 5 seconds of 
exposure to a .38 W/cm2 intensity ultra violet light. This controlled setting time 
could provide a significant advantage when compared to other adhesives if used 
in corneal transplant procedures. In giving the surgeon the choice of when to 
activate and set the adhesive, ample time would be provided to adjust the 
positioning of the donor button and to remove excess glue.   
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The bonding strength of PGSA light-activated glue, when used on 
epicardial tissue, is about three times stronger than fibrin glue and about half as 
strong as cyanoacrylate glues (See Figure 11). Since the experiments presented 
earlier by Bahar et al. indicated that fibrin glue can function well as an adjunct to 
sutures in penetrating keratoplasty through the use of a “top hat” wound cut, 
PGSA light-activated glue could provide similar, if not better, results considering 
its higher bonding strength.  
 In terms of biocompatibility and inflammation, the glue exhibited similar 
inflammatory reaction patterns to fibrin glue and better biocompatibility than 
cyanoacrylate glues. The synthetic nature of the glue also removes the risk of 
transfer of infectious factors. The breakdown products of the glue, sebacic acid, 
glycerol, and the photoinitiator components exhibited biodegradable properties. 
The glue also had significant adhesive properties even when exposed to blood 
when compared to cyanoacrylate due to its hydrophobic qualities (Lang et al., 
2014). 
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Figure 11. Magnitude of Adhesion of Various Adhesives to Epicardial 
Tissue. Cyanoacrylate glue (CA), fibrin glues, and PGSA hydrophobic light-
activated adhesive (HLAA) are compared in terms of their adhesive strength 
through a pull-off test. The various time increments shown are the ultra violet 
light exposure times required to activate the PGSA glue. PGSA HLAA reaches its 
maximal adhesion after about 5 seconds of exposure to ultra violet light. Taken 
from (Lang et al., 2014). 
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 Availability 
 The PGSA light activated glue was developed within the past year and, 
thus, robust logistics data for cost of production and storage are not readily 
available. 
Experimental Ophthalmic Surgeries Using PGSA Glue 
 There have yet to be trials or experiments using PGSA glue in ophthalmic 
surgeries given its recent development. Given the unique physiology of the eye 
and cornea, tensile strength comparisons in a corneal setting would be 
necessary in determining its potential efficacy as an adjunct or replacement to 
sutures in penetrating keratoplasty procedures. Additionally, since studies have 
previously shown that ultra violet light can be associated with keratopathies, 
keratitis, pterygium, and other eye-related malignancies, it would be beneficial to 
have data on whether the particular ultra violet light wavelengths and intensities 
for PGSA glue fixation are harmful to humans in the 5 seconds time intervals 
required for curing (Yam & Kwok, 2014).  
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DISCUSSION 
 
 The first property to consider in this search for an alternative to sutures for 
penetrating keratoplasty procedures is whether or not these alternatives can 
successfully bind the donor button in place and promote healing without 
significant risk of wound dehiscence. If the alternative cannot meet these criteria, 
even when used as an adjunct to sutures as opposed to being used as a 
replacement to sutures, then there would be no room to consider it as an 
alternative. According to the results presented by Cho et al., polyethylene glycol 
glues, when applied as an adjunct to sutures in lamellar keratoplasty procedures 
in rabbits, lead to significant amounts of wound dehiscence. Lamellar 
keratoplasty procedures provide more surface area for glue adhesion at the 
donor button and host tissue interface. Consequently, although the results 
applied only to lamellar keratoplasty procedures, the results hint that 
polyethylene glycol’s potential as an alternative to suture use in penetrating 
keratoplasty procedures may be limited. The authors proposed that the glue’s 
inherent change in volume within the first 24 hours after application was the true 
culprit for the unsatisfactory performance. They proposed that this factor lead to 
decreased epithelial healing and, thus, the dehiscence. It is for the reasons 
stated above, in conjunction with its high relative cost per milliliter, that 
polyethylene glycol glues will not be considered any further as either 
replacements or adjuncts to sutures in penetrating keratoplasty procedures.  
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 To continue on the assessment of each glue’s adhesive potential, through 
the experiments run by Bahar et al., it has been illustrated that fibrin glue can 
function well as an adjunct to suture use in “top hat” penetrating keratoplasty 
procedures. Its use resulted in fewer sutures being needed for a penetrating 
keratoplasty with 2.5 D of induced astigmatism when compared to the 3.1 D 
induced by the traditional keratoplasty and the “top hat” penetrating keratoplasty 
with no adhesive use (Bahar et al., 2008). The “top hat” wound configuration 
acted to increase the surface area for adhesion to occur as well as act as a 
mechanical support, making wound leakage and bursting occur at higher 
intraocular pressures than those necessary to occur after a standard 
keratoplasty. In the study, the investigators only used the fibrin glue Tisseel, a 
homologous fibrin glue, which have been shown to have stronger bonding 
strength than autologous glues. Overall, the study indicates a strong potential for 
biocompatible adhesives as adjuncts and perhaps eventual replacements to 
sutures in penetrating keratoplasty. However, further testing would be essential 
to determine if any adhesives currently available have the capacity to replace 
sutures entirely. 
Given that both cyanoacrylate and PGSA glue have displayed higher 
adhesive strength per square centimeter than fibrin glue in certain tissues, it is 
likely that cyanoacrylate and PGSA glue can provide equal or greater tensile 
strength if also tested under various wound configurations (Lang et al., 2014). 
Consequently, when considering tensile strength alone, PGSA, cyanoacrylate, 
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and fibrin glues are very likely to see success, at the very least, as adjuncts to 
suture use, if not as replacements. 
 One of the criteria mentioned earlier for the ideal replacement for sutures 
in penetrating keratoplasty procedures was that the alternatives did not opacify or 
occlude vision in any way. According to the published studies considered above, 
none of the adhesives still in consideration, which includes fibrin, PGSA, and 
cyanoacrylate glues, were reported to cause any sort of opacification or 
obstruction of vision.  
 The next criteria to consider is that of the ease of use of each alternative 
in a surgical setting. If the alternatives are able to provide sufficient tensile 
strength to, at the very minimum, reduce the amount of sutures required for the 
procedure, they will be able to decrease operative time significantly. As stated 
earlier, the amount of time and skill required to place all 16 of the sutures 
required in a traditional keratoplasty can be very daunting, requiring an average 
of about four minutes per suture for novice surgeons. All of the glues, barring 
polyethylene glycol glues, should be able to provide the tensile strength required 
to reduce the amount of sutures necessary which indicates that all of the glues 
remaining have the capacity to reduce operative time. 
For ease of use, in addition to reduction of operative time, it is very 
important to consider the time each glue takes to set. The time a glue takes to 
set determines the time a surgeon has to adjust the donor cornea button with 
respect to the host’s tissue. This time is also useful for removal of excess glue. 
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For the fibrin glues, this variable can be controlled by the thrombin enzyme 
concentration, which determine the reaction rate, and, for the cyanoacrylate 
glues, this can be somewhat controlled by which alkyl group the cyanoacrylate 
glue contains. Both of these glues begin to set somewhat quickly though, and 
once placed on the tissues, the control out of the surgeon’s hands. There is an 
alternative solution for fibrin glues however. Fibrin glues usually come in dual 
syringes that mix the thrombin and fibrinogen upon ejection of the glue from the 
syringe, causing the setting process to begin. The alternative solution is to 
manually mix the two components at a time of convenience. This requires that 
the fibrinogen be placed first and then thrombin can be applied when the surgeon 
ready.  
The tissue adhesive that seems to best fulfill surgical requirements is the 
PGSA glue. In having absolute control of when the glue sets, by means of 
deciding when to begin the curing light exposure, the surgeon can control the 
exact moments at which the polymer crosslinking occurs and when the glue sets. 
This enables skilled surgeons to cause the glue to set quickly after the donor 
button is properly positioned and less experienced surgeons to cause the glue to 
set as their individual pace requires. 
The next criteria to consider is that of side effects and complications 
associated with the use of the use of each of the adhesive alternatives. Fibrin 
glues have the unfortunate capacity to transmit infectious factors due to their 
synthesis from plasma. Although this factor can lead to terrible consequences, 
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modern anti-viral preparatory methods can reduce the risk of transfer significantly 
(Aizawa et al., 2008). Aside from the risk of transferring infectious diseases, fibrin 
glue is safe due to its natural biocompatibility as represented by the published 
studies discussed above. Cyanoacrylate glues, on the other hand have shown 
numerous inflammatory and irritating side effects when used on the eyes 
including side effects such as giant pupillary conjunctivitis, irritation from excess 
glue, and inflammation from the formaldehyde breakdown products. These side-
effects severely limit cyanoacrylate’s viability as an alternative to sutures since its 
use may lead to more risks than rewards. Lastly, PGSA glue has been reported 
to have similar biocompatibility profile as fibrin glues and higher biocompatibility 
than cyanoacrylate glues.  
As, discussed above, sutures have been shown to induce histologically 
identifiably inflammation. Inflamed tissue around sutures can lead to loose 
sutures, which can lead to premature suture removal, wound dehiscence, and 
perhaps even graft rejection. In having a high biocompatibility, low immune and 
inflammatory responses, and reducing the amount of required sutures, use of 
fibrin and PGSA glues could significantly improve overall penetrating keratoplasty 
outcomes. Overall, fibrin glues are likely to be the best choice when it comes to 
limiting the inflammatory reactions given the extensive and robust nature of the 
studies available that highlight these properties. On the other hand, future studies 
on the use of PGSA glue on the cornea in comparison to fibrin would help in 
 41 
evaluating their relative biocompatibility in the eye and perhaps reveal significant 
differences which could help determine the better suture alternative.  
Sutures techniques for corneal transplants requires extensive amount of 
follow-ups and testing, such as corneal topographies, in order to identify and 
remove the appropriate sutures. From the published studies considered, it has 
been shown that both fibrin adhesives and PGSA adhesives both breakdown into 
products that are naturally found in the body. For fibrin glue specifically, this 
breakdown occurs naturally as the cornea heals and overall breakdown is 
complete within the early post-operative months. Since this breakdown is 
handled by the body, there is no need to schedule appointments to address the 
glue removal. Additionally, in acting as an adjunct to suture use and reducing the 
amount of sutures required to bind the donor button in place, fibrin glue has been 
shown to reduce the initial induced astigmatism. This can also reduce the follow 
up appointments required by reducing the need of selectively removing the 
sutures in order to reduce the induced astigmatism. The reduction in astigmatism 
can also prevent or limit the risk of removing sutures prematurely for reducing 
astigmatism, which has historically shown to increase the risk of graft rejection. 
If the adhesives are to act as replacements or adjuncts to suture use, they 
need to have costs comparable to those of the sutures. Ophthalmic sutures are 
generally very fine monofilament sutures, such as the 10-0 USP designation 
nylon suture. A box of 12 of these sutures can cost approximately $300 to $400, 
equating to about $30 per suture. The price per milliliter of fibrin glue is 
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approximately $50 and the price per milliliter of cyanoacrylate is approximately 
$5. Given that the milliliter is equivalent to one cubic centimeter and that the 
average cornea has a diameter of 11.5 mm and a thickness of about .6 mm, 
about two milliliters of glue should suffice for use in a keratoplasty surgery. The 
cost of production data is not available for PGSA hydrophobic light activated 
adhesive. Also, the cost of producing fibrin glue can be reduced even further by 
adopting the high volume thrombin production techniques described by Aizawa et 
al. This could bring the overall cost of producing fibrin glue to well below $50 per 
milliliter. Overall, this indicates that the cost of performing the surgery could be 
reduced if the adhesives reduce enough of the number of required stitches to 
cover their cost.  
The last criterion to consider is that of preparation and storage of each of 
the materials. The fibrin glues usually come in dual syringes that allow for 
instantaneous mixing. Fibrin glues require frozen storage and need to be thawed 
before a procedure. The thawing takes about five minutes. Cyanoacrylate glues 
can be stored through simple refrigeration. No information about PGSA glue 
regarding its storage is available, however the glue does require mixing before 
application, which can take a few minutes.  
Conclusion 
Overall, from the studies currently available, completely replacing sutures 
for the penetrating keratoplasty procedure with adhesives would require a 
significant amount of additional studies and experiments. At this point in time, 
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using fibrin glues as an adjunct to suture use in a “top hat” penetrating 
keratoplasty is the most likely way to effectively achieve a reduction in the 
sutures required for the procedure. This would reduce the numerous suture 
based complications, inflammation, wound bursting and dehiscence, operative 
time, the skill requirements of the procedure, the follow up appointments, and 
even the overall cost of the procedure.  
Polyethylene glycol glues had the unfortunate downside of increasing in 
volume after polymerization. Cyanoacrylate glues, although inexpensive and 
highly adhesive, form crusts, cause inflammation, and potentially cause giant 
pupillary conjunctivitis. Lastly PGSA glue could prove a better fit than fibrin glue 
as an adjunct or replacement to sutures. PGSA glue displayed higher adhesive 
strength per square centimeter on pericardial tissue, can be manually cured by 
ultraviolet light at any point of the surgeon’s choosing, displayed a similar 
biocompatibility profile to fibrin glues, and is a hydrophobic glue, making it less 
affected by the aqueous nature of the fluids within the corneal environment. The 
primary downside to PGSA glue is that it was developed recently and there is still 
a distinct lack of information regarding production logistics, how it interacts with 
eye tissue, whether its adhesive strength is different when applied on the cornea 
as opposed to the heart. Upon further investigation, PGSA glue could prove to be 
a formidable replacement to suture use in the penetrating keratoplasty 
procedure. 
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Future Directions 
 In order to better understand whether or not adhesives can completely 
replace sutures for penetrating keratoplasty procedures, studies can be 
performed to test the adhesion of each glue on corneal tissue. In addition, tests 
and experiments with the aim of maximizing the surface area of the donor button 
and host interface by means of variable wound configurations would also be 
insightful. This testing, in conjunction with the knowledge of the adhesive 
strength per square centimeter of each glue, would indicate each glue’s 
maximum potential total tensile strength for each wound configuration. With this 
knowledge it would be easier to predict if sutures would still be necessary with 
different wound configurations, and, if they are, how many sutures are still 
required.  
 In addition to those tests for tensile strength, further testing on the PGSA 
glue would be very helpful. Since it was developed recently, and since the 
preliminary data showed very promising results, it may prove to be a great boon 
towards the advancement of sutureless penetrating keratoplasty procedures. 
Points of interest for study would be comparisons of the biocompatibility, tensile 
strength, and cost of PGSA glue with respect to the same properties of fibrin glue 
when used on the human cornea. Another point of interest is whether or not the 
ultraviolet light used to cure the adhesive induces unexpected side effects. These 
tests should indicate whether PGSA glue is a better candidate as an adjunct or a 
replacement to sutures than fibrin glue. PGSA glue may reduce the required 
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amount of sutures in a penetrating keratoplasty procedure by more than fibrin 
glue, or remove the need for them all together. 
 The adhesives and technologies currently available enable the possibility 
to, at the very least, reduce the amount of sutures required for the penetrating 
keratoplasty procedure. Upon further study, modifications can be implemented to 
improve the procedure’s effectiveness, have less suture related complications 
and side-effects, induce less astigmatism, and potentially cost less. This would 
increase the overall appeal and availability of corneal transplantation and 
hopefully make it more accessible to who need it most.  
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